Kiran Kumar Asarpota
Director of Finance/CFO presso ASLAN PHARMACEUTICALS LIMITED
Patrimonio netto: 14 252 $ in data 31/03/2024
Profilo
Mr. Kiran K.
Asarpota is a Chief Operating Officer & Head-Finance at Aslan Pharmaceuticals Ltd.
and a Chief Operating Officer at ASLAN Pharmaceuticals Pte Ltd.
He is on the Board of Directors at Aslan Pharmaceuticals (Shanghai) Co. Ltd.
and Aslan Pharmaceuticals Taiwan Ltd.
Mr. Asarpota was previously employed as a Group Finance Director by Global Brands Group Holding Ltd.
and a Group Finance Director by Global Brands Group Pte Ltd.
He received his undergraduate degree from Oxford Brookes University and an MBA from London South Bank University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
28/02/2023 | 115 871 ( 0.03% ) | 14 252 $ | 31/03/2024 |
Posizioni attive di Kiran Kumar Asarpota
Società | Posizione | Inizio |
---|---|---|
ASLAN PHARMACEUTICALS LIMITED | Director of Finance/CFO | 01/11/2010 |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Chief Operating Officer | - |
Aslan Pharmaceuticals Taiwan Ltd.
Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The private company is based in Taipei, Taiwan and was founded in 2014. | Director/Board Member | - |
Aslan Pharmaceuticals (Shanghai) Co. Ltd. | Director/Board Member | - |
Precedenti posizioni note di Kiran Kumar Asarpota
Società | Posizione | Fine |
---|---|---|
Global Brands Group Pte Ltd.
Global Brands Group Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Global Brands Group Pte Ltd. provides product licensing, brand management, and retail development services. The firm offers services for sports, entertainment, and lifestyle brands. Its brand partners include PGA TOUR, FIBA, FIFA, Playground Productions, Chorion, Evisu, and IPC Media. The firm also operates in Asia, Australasia, Europe, Middle East, North & South America, and South Africa. The company was founded in September 2003 by David St. George and Jonathan Sieff and is headquartered in Singapore City, Singapore. | Director of Finance/CFO | 01/01/2010 |
GLOBAL BRANDS GROUP HOLDING LIMITED | Director of Finance/CFO | 01/01/2010 |
Formazione di Kiran Kumar Asarpota
Oxford Brookes University | Undergraduate Degree |
London South Bank University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GLOBAL BRANDS GROUP HOLDING LIMITED | Consumer Non-Durables |
ASLAN PHARMACEUTICALS LIMITED | Health Technology |
Aziende private | 4 |
---|---|
Global Brands Group Pte Ltd.
Global Brands Group Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Global Brands Group Pte Ltd. provides product licensing, brand management, and retail development services. The firm offers services for sports, entertainment, and lifestyle brands. Its brand partners include PGA TOUR, FIBA, FIFA, Playground Productions, Chorion, Evisu, and IPC Media. The firm also operates in Asia, Australasia, Europe, Middle East, North & South America, and South Africa. The company was founded in September 2003 by David St. George and Jonathan Sieff and is headquartered in Singapore City, Singapore. | Commercial Services |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Aslan Pharmaceuticals Taiwan Ltd.
Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The private company is based in Taipei, Taiwan and was founded in 2014. | Health Technology |
Aslan Pharmaceuticals (Shanghai) Co. Ltd. |
- Borsa valori
- Insiders
- Kiran Kumar Asarpota